2015
DOI: 10.1007/s11302-015-9451-x
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts

Abstract: Adenosine increases coronary flow mainly through the activation of A 2A and A 2B adenosine receptors (ARs). However, the mechanisms for the regulation of coronary flow are not fully understood. We previously demonstrated that adenosine-induced increase in coronary flow is in part through NADPH oxidase (Nox) activation, which is independent of activation of either A 1 or A 3 ARs. In this study, we hypothesize that adenosine-mediated increase in coronary flow through Nox activation depends on A 2A but not A 2B A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
22
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 65 publications
(157 reference statements)
0
22
0
Order By: Relevance
“…Many adenine nucleotides including ATP and AMP are potent vasodilators, yet they serve no benefit in regulating MI/R injury 16. Furthermore, the vasodilation seen in coronary blood flow with adenosine has been previously reported to be dependent on upregulation of NADPH‐oxidase–mediated ROS formation in coronary endothelial cells 57, 58. In light of our findings that MSCs are capable of increasing adenosine levels while simultaneously preventing significant increases in ROS formation, it seems unlikely that vasodilation is the primary therapeutic mechanism at play.…”
Section: Discussionmentioning
confidence: 99%
“…Many adenine nucleotides including ATP and AMP are potent vasodilators, yet they serve no benefit in regulating MI/R injury 16. Furthermore, the vasodilation seen in coronary blood flow with adenosine has been previously reported to be dependent on upregulation of NADPH‐oxidase–mediated ROS formation in coronary endothelial cells 57, 58. In light of our findings that MSCs are capable of increasing adenosine levels while simultaneously preventing significant increases in ROS formation, it seems unlikely that vasodilation is the primary therapeutic mechanism at play.…”
Section: Discussionmentioning
confidence: 99%
“…71-73 One advantage of this technique is the ability to measure blood flow in vivo under minimally invasive conditions (intravenous catheter for contrast infusion). Previous measurements of myocardial blood flow in the mouse heart were confined to buffer-perfused isolated heart models, 74-77 which impact a variety of control mechanisms for coronary blood flow causing concerns about physiological relevance of the observations. In our study we used contrast echocardiography to measure myocardial blood flow in anesthetized mice, and these values were about 40% higher compared to the flows measured with microspheres.…”
Section: Discussionmentioning
confidence: 99%
“…Most previous efforts directed at understanding the links between metabolism and flow in the heart focused on specific metabolites, for example, adenosine 5,6 , which signal through G-protein-coupled receptors to produce vasodilation [7][8][9][10] . Although a large body of work supports the role of metabolites such as adenosine in coronary regulation, some observations have challenged this hypothesis 11,12 .…”
mentioning
confidence: 99%